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and P. D. Moorheadt
Toxicosis was induced in pregnant heifers by feeding 25,000 mg/head/day of FireMaster BP-6, a
commercial blend of polybrominated biphenyls (PBB). The PBB feeding decreased dry matter intake
approximately 50% by 4 days exposure. Emaciated animals became anorexic a few days prior to death at
33 to 66 days. Weight losses of heifers averaged 80 kg. Other clinical signs observed were dehydration,
diarrhea, excessive salivation and lacrimation, fetal death, abortion, and general depression as evidenced
by depressed heart and respiratory rates. Clinical signs were apparent after 10 days exposure and
progressively intensified along with loss of condition until death. Clinicopathologic changes included
significantly increased serum glutamic-oxaloacetic transaminase and decreased serum calcium by 30 days
exposure. Lactate dehydrogenase, urea nitrogen, and bilirubin were elevated, and serum albumin de-
creased by 36 to 40 days. Principal urine changes were decreased speciflc gravity and moderate pro-
teinuria. Pregnant heifers fed 0.25 or 250 mg/head/day for 60 days and nonpregnant heifers fed 250
mg/head/day for 180 days displayed neither clinical signs nor clinicopathologic changes indicating adverse
effects from PBB exposure. Post-exposure, all heifers exposed to PBB for 60 days calved normally with
zero calfmortality and were successfully rebred. Milk production was not different from control animals.
Birth weights ofcalves from dams exposed to 250 mg PBB/head/day were significantly greater than calves
ofdams exposed to 0 mg or 0.25 mg/head/day. PBB exposure ofdams produced no detrimental effects on
calves as indicated by clinical signs, clinicopathologic changes, or performance.
Introduction
In 1974 the industrial fire retardant FireMaster
FF-l (PBB), a pulverized form of FireMaster BP-6
with 2% calcium trisilicate added to prevent caking,
was advertently mixed with livestock ration and fed
to dairy cattle (1). Widespread attention has been
focused on the incident, a major concern being the
hazard present to the exposed livestock and con-
sumer health. Several field studies have indicated
increased cow and calf mortality, decreased milk
production, and a wide variety of nonspecific clini-
cal signs attributed to PBB exposure (2, 3). How-
ever, a field study of contaminated and noncon-
taminated herds failed to associate PBB exposure
with reported signs of toxicosis (4). The discrepan-
cies between these field study reports possibly re-
flected the great variations of levels and durations
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of exposure, farm management practices, and lack
of adequate farm records. The immediate need
arose for controlled studies to evaluate the acute
and latent health hazard present to cows and their
offspring at varying levels and duration ofexposure
to FireMaster.
Materials and Methods
Sixty dairy animals were involved in seven
studies to determine distribution and clearance of
FireMaster BP-6 and to evaluate the health hazard
present from this residue. Table 1 lists the animals
involved in the various experiments, the daily and
total amount of FireMaster received, and the dura-
tion of the experiment. Specific details of proce-
dures and animals for experiments 1, 2, 3, (5); 4 (6);
and 7 (7) have been reported previously.
Experiments 1, 2, and 3 were designed to care-
fully monitor the short-term distribution and clear-
ance of FireMaster. Changes in health of animals
were recorded by attending technicians, but no
quantitative procedure was used to evaluate health.
April 1978 83Table 1. Protocol for seven experiments on the distribution and effects of PBB on dairy cattle.
PBB Exposure
Total dose to Post
Daily body weight exposure
amount, Duration ratio, study,
Experiment Animals Status" mg days mg/kg BW days
lb I Cow P L 3000 1 4.59 1100'
2b
I Cow
I Calf
I Calf
I Calf
2 Heifers
I Heifer
3 Heifers
2 Heifers
I Heifer
3 Heifers
2 Heifers
I Heifer
3 Heifers
6 Heifers
3 Calves
I Calf
3 Calves
I Calf
3 Calves
I Calf
I Heifer
5 Heifers
4 Heifers
2 Cows
2 Cows
P L N
N
N
N
P N
P L N
P L
P N
P L N
P L
P N
P 1, N
P L1
P N
N
N
N
P L
p
p
N
N
3000
0.54
d
25,000
0
0
0
0.25
0.25
0.25
250
250
250
25,000
g
g
h
h
l
i
250
0
250
25,000
0
44
95
9
60
60
60
60
60
60
60
60
60
32-60'
160
160
160
160
160
160
180
202
202
25
25
5.95
0.78
5000
0
0
0
0.0375
0.0375
0.0375
37.5
37.5
37.5
2650
90.0
0
100
1470
0
10
44
170
640'
170
64('
170)
64('
475'
10
475'
10
475'
10
200'
200'
35
35
(I During course of experiment animals were: P
bLot 158RP of FireMaster BP-6 was used.
'Under continued observation-days as of 10-1
" Calf from Experiment I.
' Lot 6244A of FireMaster BP-6 was used.
' All animals moribund between days 33 and 66.
q Calves from Experiment 4, 0.0 mg/day heifers.
" Calves from Experiment 4, 0.25 mg/day heifer
' Calves from Experiment 4, 250 mg/day heifers
= pregnant: L = lactating; N = necropsied.
All but one of the animals involved were necrop-
sied. The surviving animal is currently under obser-
vation with health, breeding, and milk production
records being maintained.
Experiment 4 was designed to systematically and
quantitatively evaluate the health, performance,
and residue dynamics of pregnant heifers given 0 to
25 g of FireMaster for 60 days. Feed intake and
body weight measurements were recorded, along
with frequent clinical evaluations performed by a
veterinarian. Clinical evaluations included the
grading ofgeneral health and eight reported clinical
signs of PBB toxicosis (2) on a 1-10 scale, plus mea-
surement of heart rate, respiration rate, and body
temperature (6). In addition, blood and urine were
collected for clinicopathologic determinations.
Following parturition, milk production alnd breeding
records were maintained. Three animals from each
group were allotted to necropsy for histological
examination of tissues. Of these, two were necrop-
sied on day 61 and the other and her calf 10 datys
postpartum. All moribund animals wer-e also ne-
cropsied.
In experiment 5, feed intake and growth of the
calves of the heifers from experiment 4 were re-
corded, along with clinical evaluations and
clinicopathologic determinations. In addition, the
attending technician recorded daily ratings ofhealth
and evaluated the appetite, breathing, eyes. and
stool ofeach calfdaily for 180 days. Blood and urine
sampling for clinicopathologic determinations is
being continued.
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signed to monitor specific target organ effects from
PBB exposure. However, clinical observations and
blood and urine were collected to give additional
information on the overall health hazard present to
dairy animals from PBB exposure.
In all experiments the animal that were dosed
were given the FireMaster in gelatin capsules with a
balling gun to insure thatthe total dose was received
and to reduce cross-contamination. Management
practices were followed that minimized housing ef-
fects, reduced cross-contamination, and assured
that all animals had a similar environment.
The clinical evaluations of animals were per-
formed at frequent regular intervals throughout the
experiments. Previously recorded evaluations were
not available to the veterinarian at the time of each
clinical evaluation to minimize bias. Blood for
clinicopathologic determinations was collected by
venous puncture in untreated (serum) and sodium
fluoride treated (whole blood) vacuum tubes. Urine
was collected by induced micturition, filtered, and
stored with benzoate preservative. The following
serum and plasma parameters were determined:
glutamic-oxaloacetic transaminase (SGOT), al-
kaline phosphatase (AP), lactate dehydrogenase
(LDH), total protein, albumin, glucose (total re-
ducing sugars), bilirubin, urea nitrogen (BUN), uric
acid, creatinine, cholesterol, calcium, and inorganic
phosphorus. Globulin and the albumin: globulin
ratio were calculated. Urinary reducing sugars, cal-
cium, potassium, and specific gravity were mea-
sured. Urine was screened for the presence of glu-
cose, protein, ketones and blood. Color and ap-
pearance were evaluated and the urine sediment
was examined for the presence of epithelial cells,
erythrocytes, leukocytes, crystals, casts, and
mucus. Detailed descriptions of each method and
typical coefficients of variation for the chemical
determinations have been reported (8).
Results and Discussion
These results are intended to provide an overview
of our clinicopathologic findings from studies of the
effects of FireMaster in dairy cattle. Seven separate
experiments were conducted over a period of three
years under var-ying conditions and with differing
objectives. The various doses of FireMaster given
were 0.25 mg, 250 mg, 3 g, and 25 g daily for periods
of I to 202 days. In addition, calves were exposed in
l/t(o and thr-ough consumption of milk from con-
taminated dams. The results obtained are reported
in two primary categories: exposures which elicited
a toxic response and exposures which did not.
Exposures Which Did Not Elicit
a Toxic Response
The first study with FireMaster was designed to
obtain information on short-term residue dynamics.
Toxicosis was not expected, so the protocol did not
include measurements of clinicopathologic re-
sponses. No clinical signs or lesions in necropsied
animals that could be attributed to PBB exposure
were observed in mature cows given single 3 g
doses or in calves which received the residue in
utero or through milk from contaminated dams (5).
Studies to quantitate, clinicopathologic responses
precisely were designed and conducted because of
the increasing evidence of toxicity reported in field
studies ofcontaminated animals. Pregnant heifers in
experimental groups that were exposed to 0.0, 0.25,
and 250 mg FireMaster/daily for 60 days did not
exhibit signs of toxicosis (6). Intake of dry matter
and body weight significantly increased for the
three groups. Feed efficiencies were not different
among the three groups. Heart rate, respiration
rate, and body temperature were unaffected and
mean general condition scores from clinical evalua-
tions improved (Table 2). The change in the condi-
tion ofthe animals was attributed to improved man-
agement and nutrition. Clinicopathologic values of
blood and urine samples remained within reported
normal ranges for cattle (Table 3) giving no indica-
tion of a toxic response attributable to PBB. No
gross pathologic changes or changes in tissue sec-
tions were observed in animals necropsied (17).
Animals that were not necropsied have remained
under study throughout their lactation. A relation-
ship between exposure to PBB and milk production,
incidence of mastitis, and the number of insemina-
Table 2. Average general condition scores from clinical evaluations
for heifers given various doses of PBB for 60 days."
General condition scoreb
Time,
days
10-(-1)
1-10
11-20
21-30
31-40
41-50
51-60
61-80
81-1 10
111-150
151-190
PBB,
0.0
mg/day
7.9
8.0
8.3
8.5
8.5
8.6
8.5
9.1
9.3
9.6
10.0
PBB,
0.25
mg/day
7.8
8.1
8.4
8.4
8.5
8.3
8.5
9.1
9.4
10.0
10.0
PBB,
250
mg/day
8.4
8.2
8.0
8.5
8.3
8.4
8.5
9.2
9.1
9.7
10.0
PBB
25,000
mg/day
8.2
7.8
6.7
5.9
4.2
4.7
4.8
at
aI All heifers given 25,000 mg/day were moribund and necrop-
sied by day 66.
bCondition rated on a 1-10 scale, 10 = excellent condition.
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Observed
pretreatment Reported values
values in bovine
Component mean + SE" range Reference
Blood
Glucose, mg/dl 80 + jb 36-70 (9-12)
Bilirubin, mg/dl 0.12 ± 0.01 0.0-1.4 (11-13)
Uric acid, mg/dl 0.78 ± 0.04 0.0-2.08 (9, 11, 12)
Urea nitrogen, mg/dl 7.6 ± 0.4 6-27 (10-12, 14)
Cholesterol, mg/dl 93 ± 4 50-230 (9, 12, 14)
Creatinine, mg/dl 1.06 + 0.03 1.0-2.1 (10, 12, 14)
Phosphorus, mg/dl 7.2 ± 0.2 4.0-7.83 (11, 12, 14)
Calcium, mg/dl 9.3 + 0.1 9.35-12.2 (12, 14)
Total protein, g/dl 7.0 ± 0.1 5.5-8.0 (11, 12, 14, 15)
Albumin, g/dl 3.1 ± 0.1 2.3-3.7 (10, 12, 14, 15)
Globulin, g/dl 3.8 + 0.1 3.0-5.1 (10, 12, 14, 15)
Alkaline phosphatase, mU/ml 108 ± 6 50-400 (12)
Glutamic-oxaloacetic
transaminase, mU/ml 68 + 2 50-150 (12)
Lactate dehydrogenase, mU/ml 1020 ± 47 < 2000 (12)
Urine'
Specific gravity 1.031 ± 0.002 1.025-1.045 (/6)
" Mean of day - I samples for heifers given 0.0, 0.25, 250, and 25,000 mg PBB/day for 60 days or until moribund.
b Total reducing substances.
' Individual single samples.
tions required per conception was not evident in
these studies (Table 4). Milk production was con-
sidered adequate for these grade heifers as superior
animals with good milk production potentials had
not been selected for toxicity studies.
Calves from the above dams were exposed to
FireMaster through placental transmission and their
dams' milk. Mean birth weights of calves were 35,
38, and 44 kg from dams fed 0.0, 0.25, and 250 mg/
day for 60 days. Weight gains of calves by day 42,
weaning, were 18, 15, and 13 kg and after 180 days
Table 4. Summary of mean daily milk production, incidence of
mastitis, and insemination of heifers exposed to PBB.
PPB concn,
mg/day
(for 60 days)
Average
daily milk
production,
kg
Treated
clinical
Days mastitis
(no.) (no.)
Inseminations
(no.)
0.0 16.2 305 2" 3
0.0 13.0 292 lb I
0.0 16.6 299 0 4
0.25 18.4 292 0 1
0.25 15.1 269 0 1
0.25 19.6 305 1 4
250 16.8 305 0 1
250 12.7 305 0 2
250 16.0 305 2' 2
a Mastitis related to an injury to the teat.
b Mastitis related to a prepartum injury and resulted in the loss
of production of one quarter for the entire lactation.
' Persistent mastitis necessitated discontinued milking of one
quarter on day 127 of lactation.
107, 121, and 113 kg. Clinicopathologic data re-
vealed no significant changes suggesting a toxic re-
sponse associated with FireMaster exposure.
In order to determine if prolonged exposure
would elicit a toxic response, one pregnant and four
nonpregnant heifers were given 250 mg FireMaster
daily for 180 or 202 days. Clinicopathologic deter-
minations indicated no toxic effects that could be
attributed to PBB exposure. The pregnant heifer
had dystocia at parturition, which resulted in the
stillbirth of a 56*Xkg calf. Necropsy of the calf re-
vealed no abnormalities. The reproductive tract of
the cow regressed normally, and she was rebred.
In summary, analysis of clinicopathologic data
showed no toxic response in animals given either a
single 3 g dose ofFireMaster or continuous doses of
up to 250 mg/day to give an accumulative dose ofup
to 50.5 g. Actual mean concentrations of PBB res-
idue in fat tissue exceeded 30 parts per million in
animals fed 250 mg/day, exceeding the FDA
interum guideline by 100 times. The toxic syn-
dromes observed in field studies of contaminated
animals were not evident in any of these experi-
mental animals. Although at present there is no
suggestion oftoxicity, the animals will remain under
study throughout their productive lifetimes.
Exposures Which Elicited a Toxic Response
Toxicity was induced in six pregnant heifers fed
25 g doses of FireMaster daily for 32 to 60 days.
These animals consumed between 0.8 and 1.5 kg of
Environmental Health Perspectives 86FireMaster. Intake of dry matter was reduced 50%
by 4 days exposure and declined to approximately 1
kg by 30 days (Table 5). Subsequently, body weight
was significantly reduced with losses of 80 kg
among heifers surviving 40 days (Table 5). Heart
and respiratory rates progressively decreased
(Table 5). Excessive lacrimation and salivation
were observed as early as day 11 and increased
progressively in severity. Dehydration and emacia-
tion developed and persisted throughout the trial. In
four ofthe heifers, diarrhea developed and persisted
from 3 to 9 days with occasional tenesmus. Three
heifers aborted on days 30, 33, and 38, and three
had retained dead fetuses when necropsied. All
heifers were moribund within 33 to 66 days.
Changes in some clinicopathologic values oc-
curred in these heifers. SGOT and serum calcium
had a significant response by day 15. After 30 days
exposure SGOT, LDH, BUN, and bilirubin were
significantly (p < 0.01) increased and serum cal-
cium and albumin decreased from pretreatment
normals (Table 5). Although significantly different
from pretreatment, albumin and bilirubin did not
deviate from the normal range reported for cattle
(Table 3). Changes in the urine were not marked.
Urine calcium of heifers in group II was lower on
days -1 and 15. Concentrations in heifers ofGroup
IV, showed a marked decrease by day 15 and re-
mained lower until necropsy. Urine calcium con-
centrations of animals in groups I, II, and III were
Table 5. Mean values for clinical and clinicopathologic factors for heifers given polybrominated biphenyls.
Exposures, mg PBB/day
60 days 202 days,
Factor 0.0 0.25 250 25,000 250
Body weight, Pretreatment 385 393 381 372
kg End of dosing 473 512 446 291'l
Parturition 554 529 550
90 days postpartum 508 500 506
Dry matter intake, Pretreatment 7.3 8.7 6.8 7.9
kg End of dosing 9.5 10.4 8.5 < 1.0
Heart rate, Pretreatment 87 84 88 79
beats/min End of dosing 85 85 86 51
Parturition 78 84 81
90 days postpartum 74 82 84
Respiration rate, Pretreatment 44 47 43 46
inspirations/min End of dosing 40 38 37 16
Parturition 38 46 38
90 days postpartum 37 40 36
LDH, Pretreatment 918 1184 967 1012 1105
mU/l. End of dosing 1107 1193 1094 2600 1126
Parturition 1250 1231 1095 b
90 days postpartum 692 1011 954
SGOT, Pretreatment 67 70 64 71 63
mU/l. End of dosing 73 75 68 154 64
Parturition 78 80 85
90 days postpartum 63 64 52
BUN, mg/dl Pretreatment 8.0 7.5 6.7 8.5 10.5
End of dosing 9.5 9.5 7.0 40.7 7.5
Parturition 16.2 14.2 17.0
90 days postpartum 14.0 11.6 10.6
Bilirubin, Pretreatment 0.12 0.13 0.10 0.15 0.10
mg/dl End of dosing 0.12 0.12 0.13 0.38 0.0
Parturition 0.47 0.45 0.15
90 days postpartum 0.06 0.06 0.06 -
Calcium, Pretreatment 9.1 9.2 9.4 9.7 9.2
mg/dl End of dosing 9.4 9.7 9.6 8.1 9.8
Parturition 7.3 9.8 9.8
90 days postpartum 9.5 9.9 9.7
a All heifers given 25,000 mg/day became moribund after 32-60 doses and were necropsied.
b Nonpregnant heifers.
87 April 1978lower on days 150 and 190 following a ration change
to haylage on day 110. Interpretation is difficult be-
cause calcium concentrations are based on single
samples and not 24-hr collections. Samples taken
immediately prior to necropsy revealed a trace to
moderate proteinuria, a slight decrease in pH, and
decreased specific gravity. The specific gravity de-
creased from a pretreatment mean of 1.038 to a
mean of 1.017 in terminal samples. All animals were
maintained as long as possible. When death was
impending heifers were necropsied on days 33, 36,
39, 40, 41, and 66. Principle changes were observed
in the gall bladder and renal tubules. These and
other changes in tissues ofthe terminally toxic heif-
ers have been reported in detail (17).
In an experiment designed to measure renal func-
tion in PBB exposed animals, two mature cows
were given 25-g doses of FireMaster daily for 25
days and necropsied 35 days post dose (7). It was
clinically apparent that one cow was more severely
affected. The other was beginning to show clinical
signs when necropsied. Primarily a decreased ap-
petite and weight loss were observed in both with a
30% decrease in body weight of one and a 12% de-
crease in the other at necropsy. Clinicopathologic
responses for the more toxic animal were similar to
those observed in the six heifers exposed to 25
g/day (18).
The changes in routine clinicopathologic param-
eters examined in these eight animals have indi-
cated a definite toxic response in dairy animals fed
25 g/day of FireMaster, but were not specific or
sensitive so as to provide a clear indication of the
exact mechanisms of toxicity. However, target
organ effects were indicated. Several parameters
suggested that liver was affected by PBB, but ne-
crosis was not evident (17). The mild rise in biliru-
bin values, a good indicator of biliary obstruction
and hepatocellular damage, was considered a re-
flection of gall bladder changes and minimum
hepatocellular damage (17). Serum values of SGOT
and LDH peaked at approximately the time of fetal
death and/or absorption and were at least partially
attributed to uterine cell necrosis.
The increase in BUN, a good indicator of renal
damage, and the decrease in urine specific gravity
suggested FireMaster was primarily a renal toxin.
This was supported by microscopic examination of
renal tissue (17). The elevated BUN possibly re-
flected decreased flow ofurine through the tubules,
and decreased specific gravity indicated an alter-
ation in the ability of the tubules to concentrate
urine (19). The primary sites ofthe renal lesion were
distal tubules and collecting ducts which are
primarily responsible for the forming of a concen-
trated urine (19). Alterations of intrarenal blood
flow or a washout of the corticomedullary concen-
tration gradient are two mechanisms which could
affect the flow through and the reabsorption
abilities of the tubules. However, recent studies in
our laboratory have suggested these mechanisms
are not affected in PBB exposed dairy animals (7).
An effect of PBB on production or action of the
antidiuretic hormone (ADH) cannot be entirely
ruled out; however, there is no evidence from cur-
rent work to implicate the role of ADH in this syn-
drome.
The mild hypocalcemia of toxic animals was pos-
sibly due to decreased uptake of calcium from the
gastrointestinal tract because of the marked de-
crease in feed intake of the animals and/or some
disruption of the calcium metabolism. Synthesis of
the active metabolite of vitamin D (1,25-di-
hydroxycholecalciferol) which acts directly upon
its target organs, the small intestine and the bone to
mobilize calcium stores, occurs in the renal tubules
(20, 21). This suggests that the renal tubular damage
may have interfered with 1,25-dihydroxycho-
lecalciferol production or action and possibly af-
fected calcium availability. Decreased serum cal-
cium concentrations were reported in a survey of 16
low-level exposure herds (4). In our studies, effects
on serum calcium were observed only at extremely
high levels of exposure.
The clinicopathologic parameters examined indi-
cated the kidney and possibly the liver as target
organs, but were not specific enough to relate an
exact mechanism of action of PBB.
In summary, we have gained several insights into
the clinicopathological effects of PBBs in dairy cat-
tle. They are categorized as: dose response to tox-
icity, and physiological and clinical manifestation of
toxicity. Firstly, PBB toxicity as determined from
clinicopathologic parameters measured in these
studies, was not dose responsive. Instead, PBB ap-
peared to be a threshold toxin since toxicity was not
evident during exposure and in the two years fol-
lowing exposure in our experimental animals given
250 mg/day or less. Although placental transport of
PBB has been demonstrated in these animals (22)
teratogenic effects have not been observed.
In contrast, the higher dose of25 g/day elicited an
unequivocal toxic response. At this level the ani-
mals could no longer tolerate or detoxify the com-
pound(s), and toxicosis was induced. The toxic
syndrome was evidenced by a variety of clinical
signs, changes in blood and urine chemistry, and a
reproducible and specific pathological lesion in the
kidney: the mechanisms of PBB toxicity in the kid-
ney or other affected tissues (i.e., liver, gall blad-
der, etc.) could not be determined. Further research
is being conducted in our laboratory to explain the
Environmental Health Perspectives 88toxic syndrome through understanding of the pri-
mary toxicity to the target organs, the mechanisms
by which the clinical signs are elicited, and by dis-
tinguishing target organ effects from secondary ef-
fects.
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